Trial Profile
Phase IIb trial of inhaled formoterol/glycopyrrolate in patients with chronic obstructive pulmonary disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2012
Price :
$35
*
At a glance
- Drugs Formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Pearl Therapeutics
- 05 Apr 2012 New trial record